Skip to content

Silicon Laboratories

US · SLAB #1727 by market cap Listed 1970
220.21 -1.34 -0.60%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Valuation each multiple against its own 5-year range

P/B ratio 6.57 Expensive vs history 94th percentile
5-year average 3.84 · #49 of 66 in Semiconductors
P/E ratio -369.05 Cheap vs history 0th percentile
5-year average -23.48 · forward 280.16
P/S ratio 8.21 Expensive vs history 81st percentile
5-year average 6.33 · forward 6.95 · #35 of 66 in Semiconductors

Vs. peers Semiconductors

Company Market cap P/E (TTM) P/B Div yield
Silicon Laboratories (SLAB) 7.35B -367.02 6.53 0.00%
NVIDIA (NVDA) 3.03T 13.48 11.34 0.41%
Taiwan Semiconductor (TSM) 1.65T 21.63 8.50 1.18%
Broadcom (AVGO) 1.45T 38.83 14.58 0.83%
SK hynix (SKHY) 730.35B 5.15 3.15 0.03%
Advanced Micro Devices (AMD) 696.04B 92.06 10.18 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★☆☆☆ Fair value199.30 Economic moatNarrow UncertaintyHigh

Trading 9.5% above Morningstar's fair value estimate.

Fair value

Silicon Laboratories Inc is assigned a 2-star quantitative star rating, indicating our belief that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 11% premium over our quantitative fair value estimate of $199.30 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's lack of profitability undermines our estimated valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's earnings yield of 0.4% falls in the bottom 30% compared with global peers. The earnings generated by the company relative to its share price is concerning, which contributes to our view that shares are expensive.

Alternatively, the firm's balance sheet is reassuring. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of -10.8, for example, sits in the bottom 10% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. Despite our unfavorable price/fair value ratio, this characteristic is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:14 · For reference only, not investment advice and not tailored to your situation.

Silicon Laboratories discussion 0 comments

Add a comment